Building on their existing collaboration, the companies have signed a new agreement to focus on lead optimization of drug candidates identified by Variational AI’s Enki™ generative AI platform and ...
Variational AI, a Vancouver-based Healthcare Tech Company, advances Generative AI Drug Discovery by designing novel small ...
Merck & Co. has doubled down on its partnership with Variational AI, striking a deal worth up to $349 million to collaborate on small molecule candidates against two targets. Variational disclosed a ...
Amazon S3 on MSN
The surprising physics behind smarter artificial intelligence
What if AI had its own periodic table? Scientists at Emory University have just unveiled a groundbreaking mathematical ...
VANCOUVER, British Columbia — Variational AI, Inc., a generative AI drug discovery company, today announced a collaboration with Merck, known as MSD outside of the United States and Canada, to apply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback